Presepsin (soluble CD14 subtype) as a risk factor for the development of infectious and inflammatory complications in operated colorectal cancer patients
Purpose In this pilot study the dynamic of presepsin (soluble CD14 subtype, sCD14-ST) in blood serum was assessed as a possible risk factor for the development of systemic inflammatory response syndrome (SIRS) and infectious and inflammatory complications in operated colorectal cancer patients. Meth...
Main Authors: | Kayrat Shakeyev, Yermek Turgunov, Alina Ogizbayeva, Olga Avdiyenko, Miras Mugazov, Sofiko Grigolashvili, Ilya Azizov |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Society of Coloproctology
2022-12-01
|
Series: | Annals of Coloproctology |
Subjects: | |
Online Access: | http://coloproctol.org/upload/pdf/ac-2022-00115-0016.pdf |
Similar Items
-
Investigation of Plasma Presepsin (sCD14-ST) Levels in Sepsis
by: Alper TAHMAZ, et al.
Published: (2022-04-01) -
Antibody-mediated soluble CD14 stabilization prevents agitation-induced increases in presepsin levels in blood component specimens
by: Gota Morino, et al.
Published: (2021-03-01) -
Biomarkers of Bacterial Translocation and Intestinal Wall Damage in Patients With Multiple Organ Dysfunction Syndrome
by: Yermek Turgunov, et al.
Published: (2024-01-01) -
Lipopolysaccharide-binding protein as a risk factor for development of infectious and inflammatory postsurgical complications in colorectal cancer patients
by: Yermek Turgunov, et al.
Published: (2021-10-01) -
The accuracy assessment of presepsin (sCD14-ST) for mortality prediction in adult patients with sepsis and a head-to-head comparison to PCT: a meta-analysis
by: Zhu Y, et al.
Published: (2019-06-01)